STOP2030
@stop2030.org
An international partnership to implement a new two-in-one medicine for helminthiasis
We are incredibly proud to be highlighted as one of the projects in this story about EDCTP and its 20-year anniversary.
Global Health EDCTP3 embodies what public-private collaboration should be, and enables us to walk the path from research to results.
sciencebusiness.net/news/edctp-t...
Global Health EDCTP3 embodies what public-private collaboration should be, and enables us to walk the path from research to results.
sciencebusiness.net/news/edctp-t...
EDCTP: Two decades of Africa-Europe partnership delivering excellent science and life-saving innovations
Despite remarkable progress in global health, the world faces new threats, from re-emerging infections and pandemics to antimicrobial resistance and climate-related health impacts. Amid growing geopol...
sciencebusiness.net
December 16, 2025 at 9:43 AM
We are incredibly proud to be highlighted as one of the projects in this story about EDCTP and its 20-year anniversary.
Global Health EDCTP3 embodies what public-private collaboration should be, and enables us to walk the path from research to results.
sciencebusiness.net/news/edctp-t...
Global Health EDCTP3 embodies what public-private collaboration should be, and enables us to walk the path from research to results.
sciencebusiness.net/news/edctp-t...
Do we need a new approach to STH treatment?
❌ Current treatment used in mass drug administration shows poor efficacy against some species.
⚠️ Using only one drug type increases the risk of resistance emergence—a major challenge in infectious disease control.
❌ Current treatment used in mass drug administration shows poor efficacy against some species.
⚠️ Using only one drug type increases the risk of resistance emergence—a major challenge in infectious disease control.
December 1, 2025 at 9:01 AM
Do we need a new approach to STH treatment?
❌ Current treatment used in mass drug administration shows poor efficacy against some species.
⚠️ Using only one drug type increases the risk of resistance emergence—a major challenge in infectious disease control.
❌ Current treatment used in mass drug administration shows poor efficacy against some species.
⚠️ Using only one drug type increases the risk of resistance emergence—a major challenge in infectious disease control.
Albendazole monotherapy has been the standard for mass drug administration campaigns to control soil-transmitted helminths (STHs) for over a decade — but it’s no longer enough.
Take this recent study from Ethiopia 👇
Take this recent study from Ethiopia 👇
November 23, 2025 at 10:00 AM
Albendazole monotherapy has been the standard for mass drug administration campaigns to control soil-transmitted helminths (STHs) for over a decade — but it’s no longer enough.
Take this recent study from Ethiopia 👇
Take this recent study from Ethiopia 👇
The results of over a decade of progress.
Our journey for a better treatment for soil-transmitted helminths started in 2010, with a pilot project in Northern Argentina.
Our journey for a better treatment for soil-transmitted helminths started in 2010, with a pilot project in Northern Argentina.
Papers - STOP2030
stop2030.org
November 17, 2025 at 9:01 AM
The results of over a decade of progress.
Our journey for a better treatment for soil-transmitted helminths started in 2010, with a pilot project in Northern Argentina.
Our journey for a better treatment for soil-transmitted helminths started in 2010, with a pilot project in Northern Argentina.
Today we’re presenting our fixed-dose co-formulation of ivermectin and albendazole (FDC) at the Innovation Fair 2025 in Brussels — an event that brings together innovation ecosystems from Europe, Africa, and the Mediterranean.
October 23, 2025 at 10:10 AM
Today we’re presenting our fixed-dose co-formulation of ivermectin and albendazole (FDC) at the Innovation Fair 2025 in Brussels — an event that brings together innovation ecosystems from Europe, Africa, and the Mediterranean.
A glimpse into the new funding models for #NTDs R&D 📊 As funding drops, agencies and governments are exploring new approaches to ensure sustainable support for innovation and disease control. Read it here www.devex.com/news/sponsor...
The new reality of R&D funding for neglected tropical diseases
A decline in R&D investment in neglected tropical diseases threatens progress toward critical targets. For over 20 years, one nonprofit has led research on lesser-known diseases and is now seeking…
www.devex.com
October 22, 2025 at 7:06 PM
A glimpse into the new funding models for #NTDs R&D 📊 As funding drops, agencies and governments are exploring new approaches to ensure sustainable support for innovation and disease control. Read it here www.devex.com/news/sponsor...
Improve #NTD programs through social and behavioural change. The NTD NGO Network has released a quick guide to help organisations develop effective, sustainable, and context-appropriate strategies for #NTDcontrol and elimination.
Check it out here: www.ntd-ngonetwork.org/sites/nnn/fi...
Check it out here: www.ntd-ngonetwork.org/sites/nnn/fi...
www.ntd-ngonetwork.org
October 14, 2025 at 8:03 PM
Improve #NTD programs through social and behavioural change. The NTD NGO Network has released a quick guide to help organisations develop effective, sustainable, and context-appropriate strategies for #NTDcontrol and elimination.
Check it out here: www.ntd-ngonetwork.org/sites/nnn/fi...
Check it out here: www.ntd-ngonetwork.org/sites/nnn/fi...
The REALISE clinical trial is live! 🎉
Our teams in Kenya and Ghana have kicked off fieldwork for our pivotal study on the ivermectin/albendazole FDC.
20,000 children will take part to help shape the future of NTD control. 🌍💊
Read more 👉 stop2030.org/the-realise-...
Our teams in Kenya and Ghana have kicked off fieldwork for our pivotal study on the ivermectin/albendazole FDC.
20,000 children will take part to help shape the future of NTD control. 🌍💊
Read more 👉 stop2030.org/the-realise-...
The REALISE clinical begins sample collection and dosing - STOP2030
Our latest clinical trial, the REALISE study, has officially started its clinical phase. The First Patient First Visit (FPFV) took place on late September 2025, as sample collection and dosing started...
stop2030.org
October 14, 2025 at 10:26 AM
The REALISE clinical trial is live! 🎉
Our teams in Kenya and Ghana have kicked off fieldwork for our pivotal study on the ivermectin/albendazole FDC.
20,000 children will take part to help shape the future of NTD control. 🌍💊
Read more 👉 stop2030.org/the-realise-...
Our teams in Kenya and Ghana have kicked off fieldwork for our pivotal study on the ivermectin/albendazole FDC.
20,000 children will take part to help shape the future of NTD control. 🌍💊
Read more 👉 stop2030.org/the-realise-...
We’ve wrapped up over a decade of research into three materials
🔬 A look back at our 10+ year journey
🎯 The benefits of our age-based fixed ivermectin dosing strategy
💊 The results of the pivotal clinical trial evaluating the safety and efficacy of our co-formulation
stop2030.org/resources/
🔬 A look back at our 10+ year journey
🎯 The benefits of our age-based fixed ivermectin dosing strategy
💊 The results of the pivotal clinical trial evaluating the safety and efficacy of our co-formulation
stop2030.org/resources/
Resources - STOP2030
#MeetThePartners videos
stop2030.org
October 9, 2025 at 8:02 PM
We’ve wrapped up over a decade of research into three materials
🔬 A look back at our 10+ year journey
🎯 The benefits of our age-based fixed ivermectin dosing strategy
💊 The results of the pivotal clinical trial evaluating the safety and efficacy of our co-formulation
stop2030.org/resources/
🔬 A look back at our 10+ year journey
🎯 The benefits of our age-based fixed ivermectin dosing strategy
💊 The results of the pivotal clinical trial evaluating the safety and efficacy of our co-formulation
stop2030.org/resources/
To improve the lives and health of affected communities, a new treatment needs to be accepted, accessible and effectively implemented. That is why we work to gather extra evidence beyond safety and efficacy. Discover more on our website stop2030.org
Home - STOP2030
An international partnership to implement a new two-in-one medicine for helminthiasis
stop2030.org
October 6, 2025 at 8:02 PM
To improve the lives and health of affected communities, a new treatment needs to be accepted, accessible and effectively implemented. That is why we work to gather extra evidence beyond safety and efficacy. Discover more on our website stop2030.org
Our fixed-dose tablet combines two key anthelmintic drugs to control soil-transmitted helminths 👇
💊 #Albendazole, which blocks the worms’ ability to absorb glucose
💊 And #ivermectin, which paralyses and kills the worms
By combining them, we reduce the chances of resistance emergence!
#NTDs
💊 #Albendazole, which blocks the worms’ ability to absorb glucose
💊 And #ivermectin, which paralyses and kills the worms
By combining them, we reduce the chances of resistance emergence!
#NTDs
October 1, 2025 at 8:01 PM
Our fixed-dose tablet combines two key anthelmintic drugs to control soil-transmitted helminths 👇
💊 #Albendazole, which blocks the worms’ ability to absorb glucose
💊 And #ivermectin, which paralyses and kills the worms
By combining them, we reduce the chances of resistance emergence!
#NTDs
💊 #Albendazole, which blocks the worms’ ability to absorb glucose
💊 And #ivermectin, which paralyses and kills the worms
By combining them, we reduce the chances of resistance emergence!
#NTDs
The REALISE study, our clinical trial to evaluate the safety in large populations of our fixed-dose coformulation of ivermectin and albendazole (FDC), has reached an important milestone.
October 1, 2025 at 2:43 PM
The REALISE study, our clinical trial to evaluate the safety in large populations of our fixed-dose coformulation of ivermectin and albendazole (FDC), has reached an important milestone.